Hyrimoz and Nerve injury - a phase IV clinical study of FDA data

Summary:

Nerve injury is reported as a side effect among people who take Hyrimoz (adalimumab-adaz), especially for people who are female, 30-39 old, have been taking the drug for 6 - 12 months also take Rifaximin, and have Crohn's disease.

The phase IV clinical study analyzes which people have Nerve injury when taking Hyrimoz. It is created by eHealthMe based on reports of 4,629 people who have side effects when taking Hyrimoz from the FDA, and is updated regularly.

What is Hyrimoz?

Hyrimoz has active ingredients of adalimumab-adaz. eHealthMe is studying from 4,635 Hyrimoz users. Check the latest studies of Hyrimoz.

What is Nerve injury?

Nerve injury is found to be associated with 927 drugs and 996 conditions by eHealthMe. Check the latest studies of Nerve injury.

On Jul, 16, 2026

4,629 people reported to have side effects when taking Hyrimoz.
Among them, 30 people (0.65%) have Nerve injury.

Among these 30 people:

How long have people been on Hyrimoz when they have Nerve injury? *

What is the gender of people who have Nerve injury when taking Hyrimoz? *

female: 100 %
male: 0.0 %

What is the age of people who have Nerve injury when taking Hyrimoz? *

What are other drugs people take besides Hyrimoz? *

What are other side effects people have besides Nerve injury? *

Diarrhea: 26 people, 86.67%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 26 people, 86.67%
Pancreatitis (inflammation of pancreas): 26 people, 86.67%
Small Intestinal Obstruction (blockage in small intestine): 26 people, 86.67%
Incontinence (lack of moderation or self-control): 26 people, 86.67%
Pneumonia: 25 people, 83.33%
Quality Of Life Decreased: 24 people, 80.00%
Drug Ineffective: 24 people, 80.00%
Drug Specific Antibody Present: 6 people, 20.00%
Chronic Kidney Disease: 2 people, 6.67%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 26 people, 86.67%
Toothaches (tooth pain): 2 people, 6.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 6.67%
Hidradenitis (chronic disease of a type of sweat gland): 2 people, 6.67%
Diabetes: 2 people, 6.67%
Bone Disorder: 2 people, 6.67%
Blood Pressure Abnormal: 2 people, 6.67%
Abscess (pus): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Hyrimoz and have Nerve injury?

- Check whether Nerve injury is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hyrimoz:

Hyrimoz (4,635 reports)

Nerve injury treatments and more:

Nerve injury (22,217 reports)

Browse all side effects of Hyrimoz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nerve injury:

Nerve injury (927 drugs)

Browse all the conditions that are associated with Nerve injury:

Nerve injury (996 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on adalimumab-adaz (the active ingredients of Hyrimoz) and Hyrimoz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.